Betta Pharmaceuticals Co., Ltd. (SHE:300558)

Betta Pharmaceuticals Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jan 1, 2022	Dec 31, 2020
Operating Revenue	2,827	2,417	2,342	2,206	1,824
Other Revenue	64.95	39.41	34.18	40.05	46.19
Revenue	2,892	2,456	2,377	2,246	1,870
Revenue Growth (YoY)	17.74%	3.35%	5.82%	20.08%	20.36%
Cost of Revenue	538.52	404.48	268.69	174.44	138.9
Gross Profit	2,353	2,052	2,108	2,071	1,731
Selling, General & Admin	1,363	1,116	1,234	1,141	946.77
Research & Development	501.9	640.14	699.9	565.95	362.85
Other Operating Expenses	18.19	10.62	-34.51	15.24	6.99
Operating Expenses	1,876	1,772	1,901	1,723	1,317
Operating Income	476.96	279.88	206.96	348.77	414.79
Interest Expense	-45.49	-54.95	-195.8	-15.78	-39.86
Interest & Investment Income	6.78	10.23	10.88	33.35	298.46
Currency Exchange Gain (Loss)	4.14	6.72	9.55	-3.63	-8.42
Other Non Operating Income (Expenses)	-1.45	-4.96	-9	-0.84	2.03
EBT Excluding Unusual Items	440.94	236.92	22.59	361.88	666.99
Gain (Loss) on Sale of Investments	-40.97	-13.67	-20.62	1.01	-12.42
Gain (Loss) on Sale of Assets	-0.59	-0.01	88.61	0.07	-1.7
Asset Writedown	-28.05	-1.07	-3.01	-0.03	-
Other Unusual Items	22.83	99.9	-	27.01	13.79
Pretax Income	394.16	322.07	87.57	389.93	666.66
Income Tax Expense	7.18	-11.54	-37.19	10.37	65.58
Earnings From Continuing Operations	386.98	333.62	124.76	379.56	601.09
Minority Interest in Earnings	15.59	14.42	20.66	3.51	5.27
Net Income	402.57	348.03	145.42	383.07	606.36
Net Income to Common	402.57	348.03	145.42	383.07	606.36
Net Income Growth	15.67%	139.33%	-62.04%	-36.83%	162.70%
Shares Outstanding (Basic)	419	419	416	416	404
Shares Outstanding (Diluted)	419	419	416	416	407
Shares Change (YoY)	0.01%	0.72%	-0.02%	2.32%	1.09%
EPS (Basic)	0.96	0.83	0.35	0.92	1.50
EPS (Diluted)	0.96	0.83	0.35	0.92	1.49
EPS Growth	15.66%	137.47%	-62.01%	-38.26%	161.40%
Free Cash Flow	83.58	-181.79	-703.8	-231.75	-39.81
Free Cash Flow Per Share	0.20	-0.43	-1.69	-0.56	-0.10
Dividend Per Share	0.200	0.170	0.070	0.250	0.310
Dividend Growth	17.65%	142.86%	-72.00%	-19.36%	63.16%
Gross Margin	81.38%	83.53%	88.69%	92.23%	92.57%
Operating Margin	16.49%	11.39%	8.71%	15.53%	22.18%
Profit Margin	13.92%	14.17%	6.12%	17.06%	32.42%
Free Cash Flow Margin	2.89%	-7.40%	-29.61%	-10.32%	-2.13%
EBITDA	845.1	578.14	453.58	517.89	569.95
EBITDA Margin	29.22%	23.54%	19.09%	23.06%	30.47%
D&A For EBITDA	368.14	298.26	246.62	169.12	155.16
EBIT	476.96	279.88	206.96	348.77	414.79
EBIT Margin	16.49%	11.39%	8.71%	15.53%	22.18%
Effective Tax Rate	1.82%	-	-	2.66%	9.84%
Revenue as Reported	2,892	2,456	2,377	2,246	1,870
Advertising Expenses	-	-	414.75	459.29	376.61

Updated Oct 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.